Katherine Knox, University of Saskatchewan

Research

Read how they describe their research on their University of Saskatchewan profile.

Latest papers

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) · 2026
Experiences of people with multiple sclerosis and clinicians in using cognitive behavioural therapies for hidden symptoms: a systematic review and meta-aggregation.
Journal of neurology · 2024
Impact of comorbidity on hospitalizations in individuals newly diagnosed with multiple sclerosis: A longitudinal population-based study.
Multiple sclerosis and related disorders · 2020

All 9 publications

Latest funding

Development of an online toolkit for the implementation of mindfulness-based interventions in people with multiple sclerosis
CIHR · 2024 · Co-investigator
$49,999
Accelerating Canadian Rehabilitation Research in Multiple Sclerosis
CIHR · 2022 · Co-investigator
$10,000

All 2 grants and awards

9 publications.

01

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.

Kowalec K, Manouchehrinia A, Kingwell E, Carruthers R, Marrie RA, Evans C, Rotstein D, Kuan AJ, Luo W, Luo D, Desrochers B, Jokubaitis VG, Lechner-Scott J, Maltby VE, Groen K, Wright GE, Drögemöller BI, Bernatsky S, Levin MC, Knox K, Maruf AA, Zhong M, Alfredsson L, Hillert J, Kockum I, Olsson T, Stridh P, Shchetynsky K, Dever K, MacIsaac J, Kobor MS, Tremlett H

Multiple sclerosis (Houndmills, Basingstoke, England)2026Open Access

DOI: 10.1177/13524585261471335 PMID: 42608789

02

Experiences of people with multiple sclerosis and clinicians in using cognitive behavioural therapies for hidden symptoms: a systematic review and meta-aggregation.

Feng G, Posa S, Sureshkumar A, Simpson S, Bruno T, Morrow SA, Donkers S, Knox K, Feinstein A, Bayley M, Munce S, Simpson R

Journal of neurology202412 citationsOpen Access

DOI: 10.1007/s00415-023-12116-z PMID: 38219252

03

Impact of comorbidity on hospitalizations in individuals newly diagnosed with multiple sclerosis: A longitudinal population-based study.

Al-Sakran L, Marrie RA, Blackburn D, Knox K, Evans C

Multiple sclerosis and related disorders202017 citationsOpen Access

DOI: 10.1016/j.msard.2020.101955 PMID: 32000120

04

Association between disease-modifying therapies for multiple sclerosis and healthcare utilisation on a population level: a retrospective cohort study.

Al-Sakran L, Marrie RA, Blackburn D, Knox K, Evans C

BMJ open20199 citationsOpen Access

DOI: 10.1136/bmjopen-2019-033599 PMID: 31772108

05

Access to health and support services: perspectives of people living with a long-term traumatic spinal cord injury in rural and urban areas.

Goodridge D, Rogers M, Klassen L, Jeffery B, Knox K, Rohatinsky N, Linassi G

Disability and rehabilitation201597 citations

DOI: 10.3109/09638288.2014.972593 PMID: 25332089

06

Predictors of institutionalization for people with multiple sclerosis.

Thorpe LU, Knox K, Jalbert R, Hyun-Ja Lim J, Nickel D, Hader WJ

Disability and health journal2015

DOI: 10.1016/j.dhjo.2014.10.002 PMID: 25578399

07

Pharmacogenomics of interferon-β in multiple sclerosis: What has been accomplished and how can we ensure future progress?

Rebecca J. Carlson, J. Ronald Doucette, Katherine B. Knox, Adil J. Nazarali

Cytokine & Growth Factor Reviews20149 citations

DOI: 10.1016/j.cytogfr.2014.10.008 PMID: 25524087

08

Step-length variability in minimally disabled women with multiple sclerosis or clinically isolated syndrome.

Flegel M, Knox K, Nickel D

International journal of MS care2012

DOI: 10.7224/1537-2073-14.1.26 PMID: 24453729

09

How to measure fatigue in epilepsy? The validation of three scales for clinical use.

Hernandez-Ronquillo L, Moien-Afshari F, Knox K, Britz J, Tellez-Zenteno JF

Epilepsy research2011

DOI: 10.1016/j.eplepsyres.2011.03.010 PMID: 21482076

Development of an online toolkit for the implementation of mindfulness-based interventions in people with multiple sclerosis

Co-investigatorCIHR2024Planning and Dissemination Grant - Institute Community Support

Principal investigators: Simpson, Robert

Keywords: Implementation; Integrated Knowledge Translation; Mindfulness; Multiple Sclerosis

$49,999

Accelerating Canadian Rehabilitation Research in Multiple Sclerosis

Co-investigatorCIHR2022Planning and Dissemination Grant - Institute Community Support

Principal investigators: Ploughman, Michelle E

Keywords: Clinical Trials; Consensus; Multiple Sclerosis; Patient-Oriented Research; Quality Of Life; Rehabilitation

$10,000

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Frequent collaborators

Department of Medicine
Physical Medicine and Rehabilitation
Department of Community Health and Epidemiology
Department of Psychiatry
Physical Medicine and Rehabilitaion
Medicine/Neurology
College of Pharmacy
Other

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Knox, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]